416 related articles for article (PubMed ID: 16196367)
1. beta-Lactam resistance phenotype determination in Escherichia coli isolates from University Malaya Medical Centre.
Wong JS; Mohd Azri ZA; Subramaniam G; Ho SE; Palasubramaniam S; Navaratnam P
Malays J Pathol; 2003 Dec; 25(2):113-9. PubMed ID: 16196367
[TBL] [Abstract][Full Text] [Related]
2. SHV-5 extended-spectrum beta-lactamases in clinical isolates of Escherichia coli in Malaysia.
Subramaniam G; Palasubramaniam S; Navaratnam P
Indian J Med Microbiol; 2006 Jul; 24(3):205-7. PubMed ID: 16912441
[TBL] [Abstract][Full Text] [Related]
3. Evaluation and updating of the Osiris expert system for identification of Escherichia coli beta-lactam resistance phenotypes.
Bert F; Juvin M; Ould-Hocine Z; Clarebout G; Keller E; Lambert N; Arlet G
J Clin Microbiol; 2005 Apr; 43(4):1846-50. PubMed ID: 15815007
[TBL] [Abstract][Full Text] [Related]
4. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
Tofteland S; Haldorsen B; Dahl KH; Simonsen GS; Steinbakk M; Walsh TR; Sundsfjord A;
J Clin Microbiol; 2007 Jan; 45(1):199-205. PubMed ID: 17079502
[TBL] [Abstract][Full Text] [Related]
5. [Errors of the agar diffusion method to predict Escherichia coli's susceptibility to ampicillin-sulbactam and amoxicillin-clavulanic acid].
Villar HE; Jugo MB; Fernández-Lausi A; Farinati AE
Enferm Infecc Microbiol Clin; 1996 May; 14(5):308-10. PubMed ID: 8744371
[TBL] [Abstract][Full Text] [Related]
6. Novel mechanisms of resistance to β-lactam antibiotics in Haemophilus parainfluenzae: β-lactamase-negative ampicillin resistance and inhibitor-resistant TEM β-lactamases.
García-Cobos S; Arroyo M; Campos J; Pérez-Vázquez M; Aracil B; Cercenado E; Orden B; Lara N; Oteo J
J Antimicrob Chemother; 2013 May; 68(5):1054-9. PubMed ID: 23335113
[TBL] [Abstract][Full Text] [Related]
7. Correlation of in vitro susceptibility testing results for amoxicillin-clavulanate and ampicillin-sulbactam using a panel of beta-lactamase-producing Enterobacteriaceae.
Siu LK; Cheng WL; Ho PL; Ng WS; Chau PY; Lo JY
APMIS; 1998 Sep; 106(9):917-20. PubMed ID: 9808419
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of extended-spectrum beta-lactamases-producing isolates over a 1-year period at a University Hospital in Oman.
Rafay AM; Al-Muharrmi Z; Toki R
Saudi Med J; 2007 Jan; 28(1):22-7. PubMed ID: 17206284
[TBL] [Abstract][Full Text] [Related]
10. Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different beta-lactam resistance phenotypes.
Oliver A; Pérez-Vázquez M; Martínez-Ferrer M; Baquero F; De Rafael L; Cantón R
Antimicrob Agents Chemother; 1999 Apr; 43(4):862-7. PubMed ID: 10103192
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of extended-spectrum beta-lactamase and class 1 integron integrase gene intl1 in Escherichia coli from Thai patients and healthy adults.
Pongpech P; Naenna P; Taipobsakul Y; Tribuddharat C; Srifuengfung S
Southeast Asian J Trop Med Public Health; 2008 May; 39(3):425-33. PubMed ID: 18564681
[TBL] [Abstract][Full Text] [Related]
12. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
13. Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations.
Zhao WH; Hu ZQ; Chen G; Ito R; Shimamura T
Chemotherapy; 2008; 54(1):31-7. PubMed ID: 18063864
[TBL] [Abstract][Full Text] [Related]
14. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli.
Rodriguez-Villalobos H; Malaviolle V; Frankard J; de Mendonça R; Nonhoff C; Struelens MJ
J Antimicrob Chemother; 2006 Apr; 57(4):771-4. PubMed ID: 16501056
[TBL] [Abstract][Full Text] [Related]
16. Occurrence and diversity of integrons and beta-lactamase genes among ampicillin-resistant isolates from estuarine waters.
Henriques IS; Fonseca F; Alves A; Saavedra MJ; Correia A
Res Microbiol; 2006 Dec; 157(10):938-47. PubMed ID: 17125975
[TBL] [Abstract][Full Text] [Related]
17. [Resistance to amoxicillin and amoxicillin-clavulanic acid combination of 231 clinical strains of Escherichia coli, isolated in 1992 at the Cochin Hospital].
Bémer-Melchior P; Gilly L; Jugroot-Klotz K; Brun T; Névot P; Paul G
Pathol Biol (Paris); 1995 Nov; 43(9):760-5. PubMed ID: 8746097
[TBL] [Abstract][Full Text] [Related]
18. CMT-type beta-lactamase TEM-125, an emerging problem for extended-spectrum beta-lactamase detection.
Robin F; Delmas J; Archambaud M; Schweitzer C; Chanal C; Bonnet R
Antimicrob Agents Chemother; 2006 Jul; 50(7):2403-8. PubMed ID: 16801418
[TBL] [Abstract][Full Text] [Related]
19. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
Palasubramaniam S; Muniandy S; Navaratnam P
J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of type b beta-lactamase-non-producing ampicillin-resistant Haemophilus influenzae in meningitis: the situation in Japan where Hib vaccine has not been introduced.
Hasegawa K; Kobayashi R; Takada E; Ono A; Chiba N; Morozumi M; Iwata S; Sunakawa K; Ubukata K;
J Antimicrob Chemother; 2006 Jun; 57(6):1077-82. PubMed ID: 16617062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
